NEW YORK, July 28, 2023 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR). To receive updates on the lawsuit, fill out the form:…
NEW YORK, July 28, 2023 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR). To receive updates on the lawsuit, fill out the form:…